Zimmer Introduces New CLS Brevius Hip Stem with Kinectiv Technology in the United States

WARSAW, Ind., Dec. 8, 2011 /PRNewswire/ — Zimmer Holdings, Inc. (NYSE: ZMH;
SIX: ZMH), a global leader in musculoskeletal care, today announced the
availability of its CLS® Brevius(TM) Hip Stem with Kinectiv® Technology in the
United States. This new technology enables surgeons to better match patients’
individual anatomies with modular neck options designed for independent,
intraoperative adjustments.

“Following its introduction in Europe earlier this year, we have received
excellent clinical feedback on the performance of the new CLS Brevius Stem,”
said Jeff McCaulley, President, Zimmer Reconstructive. “Incorporating Kinectiv
Technology to this new stem provides unparalleled intraoperative flexibility for
our customers to restore their patients’ anatomies.”

The new hip stem is based on the Zimmer CLS Spotorno® Stem, one of the most
reliable implants worldwide with more than 25 years of clinical use. Since its
introduction in the 1980s, the CLS Spotorno Stem has been used in more than
560,000 total hip arthroplasty procedures around the world. The CLS Spotorno
Stem is characterized by excellent primary and rotational stability in
uncemented total hip arthroplasty.

Building on this history of clinical success, the new CLS Brevius Hip Stem
provides greater intraoperative flexibility with the addition of Kinectiv
Technology. Kinectiv Technology offers a wide array of head center locations,
enabling independent, intraoperative control of leg length, offset and version
for a more accurate restoration of the patient’s natural anatomy. The CLS
Brevius Stem with Kinectiv Technology is shorter than conventional stems,
providing greater bone conservation compared with the original CLS Spotorno
Stem.

For more information about the advantages of CLS Brevius Stem with Kinectiv
Technology, please visit www.zimmer.com.

About the Company
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops,
manufactures and markets orthopaedic reconstructive, spinal and trauma devices,
dental implants, and related surgical products. Zimmer has operations in more
than 25 countries around the world and sells products in more than 100
countries. Zimmer’s 2010 sales were approximately $4.2 billion. The Company is
supported by the efforts of more than 8,000 employees worldwide.

Zimmer Safe Harbor Statement
This press release contains forward-looking statements within the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995 based on
current expectations, estimates, forecasts and projections about the
orthopaedics industry, management’s beliefs and assumptions made by management.
Forward-looking statements may be identified by the use of forward-looking terms
such as “may,” “will,” “expects,” “believes,” “anticipates,” “plans,”
“estimates,” “projects,” “assumes,” “guides,” “targets,” “forecasts,” and
“seeks” or the negative of such terms or other variations on such terms or
comparable terminology. These statements are not guarantees of future
performance and involve risks, uncertainties and assumptions that could cause
actual outcomes and results to differ materially. For a list and description of
such risks and uncertainties, see our periodic reports filed with the U.S.
Securities and Exchange Commission. We disclaim any intention or obligation to
update or revise any forward-looking statements, whether as a result of new
information, future events or otherwise, except as may be set forth in our
periodic reports. Readers of this document are cautioned not to place undue
reliance on these forward-looking statements, since, while we believe the
assumptions on which the forward-looking statements are based are reasonable,
there can be no assurance that these forward-looking statements will prove to be
accurate. This cautionary statement is applicable to all forward-looking
statements contained in this document.